Marinus Pharmaceuticals (MEX:MRNS) Days Payable : 616.72 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Marinus Pharmaceuticals Days Payable?

Marinus Pharmaceuticals's average Accounts Payable for the three months ended in Mar. 2024 was MXN84.8 Mil. Marinus Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2024 was MXN12.5 Mil. Hence, Marinus Pharmaceuticals's Days Payable for the three months ended in Mar. 2024 was 616.72.

The historical rank and industry rank for Marinus Pharmaceuticals's Days Payable or its related term are showing as below:

MEX:MRNS' s Days Payable Range Over the Past 10 Years
Min: 573.71 Med: 798.7 Max: 4072.43
Current: 573.71

During the past 12 years, Marinus Pharmaceuticals's highest Days Payable was 4072.43. The lowest was 573.71. And the median was 798.70.

MEX:MRNS's Days Payable is ranked better than
76.98% of 721 companies
in the Biotechnology industry
Industry Median: 148.78 vs MEX:MRNS: 573.71

Marinus Pharmaceuticals's Days Payable declined from Mar. 2023 (2,057.88) to Mar. 2024 (616.72). It may suggest that Marinus Pharmaceuticals accelerated paying its suppliers.

Marinus Pharmaceuticals Days Payable Historical Data

The historical data trend for Marinus Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinus Pharmaceuticals Days Payable Chart

Marinus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

650.74

4,159.84

861.24

Marinus Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															2,057.88	827.17	490.48	344.52	616.72

Competitive Comparison of Marinus Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Marinus Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marinus Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinus Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Marinus Pharmaceuticals's Days Payable falls into.

Marinus Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Marinus Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (86.972	+	67.948)	/	2 )	/	32.828	*	365
=	77.46					/	32.828	*	365
=	861.24

Marinus Pharmaceuticals's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (67.948	+	101.652)	/	2 )	/	12.547	*	365 / 4
=	84.8					/	12.547	*	365 / 4
=	616.72

Marinus Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Marinus Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinus Pharmaceuticals (MEX:MRNS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinus Pharmaceuticals Inc (MEX:MRNS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MRNS:USA 0JYL:UK 61Y:Germany

Address

100 Matsonford Road, Suite 500, 5 Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.marinuspharma.com

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.